Meloxicam 7.5mg Treatment of rheumatoid arthritis, osteoarthritis pain (3 blisters x 10 tablets)
Dosage form Box of 3 blisters x 10 tablets
Specifications Meloxicam
Ingredient
| Composition information | Content |
| Meloxicam | 7.5mg |
Uses
indications
Meloxicam 7.5 mg drug is indicated in the following cases:
Pharmacological
Meloxicam is Oxicam's derivatives of nonsteroidal anti -inflammatory groups with anti -inflammatory, analgesic, fever -reducing properties. Meloxicam has strong anti -inflammatory properties for many types of inflammation, due to the ability to inhibit biosynthesis of prostaglandin, intermediate inflammatory substances. The drug has a selective inhibitory effect on cyclooxygenase - 2 (COX - 2).
Dynamic pharmacokinetics
Meloxicam is well absorbed through the gastrointestinal tract, oral bioavailability reaches 89% compared to intravenous intravenous, very little food affects absorption. About 99% associated with plasma protein.
Good diffuse drugs into joint fluid, concentration in joint fluid is equivalent to 50% of plasma concentrations, free types of drugs in joint fluid is 2.5 times higher in plasma because there is less protein in joint fluid.
Meloxicam is almost completely metabolized in the liver with the main catalyst of CYP2C9 and a small part of CYP3A4. The metabolites are no longer active and excreted mainly through urine and feces. A small amount of drugs without metabolism excreted through urine and feces.
Average half -cancellation time. In humans mitigation or medium function or kidney function (creatinine clearance> 20 ml/ min) does not need to adjust the dose of meloxicam. Meloxicam cannot be separated.
Before taking Meloxicam 7.5mg Treatment of rheumatoid arthritis, osteoarthritis pain (3 blisters x 10 tablets)
How to use
Meloxicam 7.5 mg oral medication.
Patriarchal background at meals.
Dosage
Adults:
Maximum daily dose is recommended 15 mg.
Other similarities:
What to do when overdose? What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.
Side Effects
When using Meloxicam 7.5 mg, you may experience unwanted effects (ADR).
Common: digestive disorders, nausea, vomiting, abdominal pain, constipation, bloating, diarrhea, anemia, itching, skin rash, headache, edema. Uncommon: Mild increasing transaminase, bilirubin, belching, esophagitis, stomach -duodenal ulcer, potential gastrointestinal bleeding; leukopenia, thrombocytopenia; stomatitis, urticaria; Hypertension, chest drum, flushed face; increase creatinine and blood urea levels; Dizziness, tinnitus and drowsiness.
Rare: colitis, gastrointestinal ulcers, duodenum, hepatitis, gastritis; Increasing skin sensitivity to light, diverse rash, Stevens - Johnson syndrome, Lyell syndrome, bronchial asthma attacks; Neurological fleet, anaphylaxis.
Instructions on how to handle ADR: When the side effects of the drug are encountered, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.
Warnings
Before using the drug you need to read the instructions carefully and refer to the information below.
Contraindicated
PMS-Meloxicam 7.5 mg contraindicated in the following cases:
Bronchial asthma, nasal polyps, nerveema or quincke edema, urticaria after taking aspirin or other nonsteroidal anti -inflammatory drugs. Severe liver failure and severe kidney failure without dialysis. Progressive peptic ulcer. Pregnant and lactating women. Meloxicam must be very careful in patients with gastrointestinal pathology or being treated with anticoagulant drugs because the drug can cause stomach - duodenal ulcer, causing bleeding. To minimize unwanted effects, the lowest dose should be used in the shortest possible time. During the use of drugs with abnormalities on the skin, mucosa or signs of ulcer or gastrointestinal bleeding must stop the drug immediately. Meloxicam inhibits prostaglandin synthesis in the kidneys leading to reduced renal perfusion. Patients who have reduced blood flow to the kidneys or hypoglycemia such as heart failure, nephrotic syndrome, cirrhosis, severe kidney disease, are taking diuretics or are performing large surgery, which need to check the volume of urine and kidney function before using Meloxicam. Meloxicam can cause a slight increase in transaminase or different liver function assessment parameters. When these parameters rise beyond the normal limit of meaning or prolonged increase, Meloxicam must be stopped. In patients with cirrhosis but at a stable stage when taking the drug is not careful to reduce the dose. Elderly patients with poor liver, kidney and heart function should not use Meloxicam. The drug does not affect the ability to drive and operate machinery, but can cause unwanted effects such as dizziness, drowsiness, so avoid using Meloxicam while participating in these activities. Experimental research does not see evidence of Meloxicam's teratogenic evidence. However, Meloxicam is recommended not to be used for pregnant women, especially in the last 3 months of pregnancy for fear of early closed arterioscleros or other complications for the fetus. should not use Meloxicam. If you need to use medication for mothers, you should not breastfeed. should not be coordinated: Meloxicam with other nonsteroidal anti -inflammatory drugs, anticoagulant oral medications, ticlopidin, heparin using systemic sugar, thrombolytic drugs. Precautions: Meloxicam increases the toxicity on the kidneys of ciclosporin. Meloxicam reduces the hypotension effect of high blood pressure treatment. cholestyramin increases the elimination of meloxicam. Meloxicam can increase bleeding, so bleeding must be monitored when used with warfarin. Meloxicam reduces the diuretic effect of Furosemid and the thiazid group. Be cautious when used
The ability to drive and operate machinery
Pregnancy
breastfeeding period
Drug interaction
Storage
less than 30 ° C, avoid moisture and light.
Other drugs
- Aerius
- CIPROXIN 500MG TABLETS
- CLEXANE 60MG/0.6ML SYRINGES
- DEXAMFETAMINE SULFATE 5MG TABLETS
- PROSTAMEN SOFT CAPSULES
- RUPAFIN 10MG TABLETS
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions